Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Express Scripts
McKinsey
Healthtrust
Cerilliant
Cipla
Covington
UBS
Deloitte
Fish and Richardson

Generated: February 21, 2018

DrugPatentWatch Database Preview

CATAPRES-TTS-3 Drug Profile

« Back to Dashboard

Which patents cover Catapres-tts-3, and what generic alternatives are available?

Catapres-tts-3 is a drug marketed by Boehringer Ingelheim and is included in one NDA.

The generic ingredient in CATAPRES-TTS-3 is clonidine. There are twenty-two drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the clonidine profile page.
Drug patent expirations by year for CATAPRES-TTS-3
Pharmacology for CATAPRES-TTS-3
Medical Subject Heading (MeSH) Categories for CATAPRES-TTS-3

US Patents and Regulatory Information for CATAPRES-TTS-3

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boehringer Ingelheim CATAPRES-TTS-3 clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 018891-003 Oct 10, 1984 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for CATAPRES-TTS-3

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim CATAPRES-TTS-3 clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 018891-003 Oct 10, 1984 ➤ Sign Up ➤ Sign Up
Boehringer Ingelheim CATAPRES-TTS-3 clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 018891-003 Oct 10, 1984 ➤ Sign Up ➤ Sign Up
Boehringer Ingelheim CATAPRES-TTS-3 clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 018891-003 Oct 10, 1984 ➤ Sign Up ➤ Sign Up
Boehringer Ingelheim CATAPRES-TTS-3 clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 018891-003 Oct 10, 1984 ➤ Sign Up ➤ Sign Up
Boehringer Ingelheim CATAPRES-TTS-3 clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 018891-003 Oct 10, 1984 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Citi
Deloitte
Covington
US Army
McKinsey
Harvard Business School
Federal Trade Commission
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot